Literature DB >> 15465398

Heart failure in Parkinson's disease: analysis of the United States medicare current beneficiary survey.

T A Zesiewicz1, J A Strom, A R Borenstein, R A Hauser, C R Cimino, H L Fontanet, G B Cintron, J F Staffetti, P B Dunne, K L Sullivan.   

Abstract

OBJECTIVE: We sought to examine the prevalence of heart failure in elderly PD versus non-PD patients using a national sample of Medicare beneficiaries in the United States. SCOPE: The prevalence of heart failure in elderly PD patients was 2.27 times that of non-PD patients (19.4% versus 8.7%, 95% CI = 1.43-3.60, p 0.0005), and remained twice as high after excluding patients with stroke and possible vascular parkinsonism.
CONCLUSIONS: In this cross-sectional study of a national Medicare database, heart failure occurred twice as frequently in elderly PD patients as in non-PD patients. Prospective studies are warranted to verify these findings.

Entities:  

Mesh:

Year:  2004        PMID: 15465398     DOI: 10.1016/j.parkreldis.2004.04.001

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  24 in total

1.  Impaired mitophagy at the heart of injury.

Authors:  Roberta A Gottlieb; Robert M Mentzer; Phyllis-Jean Linton
Journal:  Autophagy       Date:  2011-12       Impact factor: 16.016

Review 2.  Mitochondrial dynamics and mitophagy in Parkinson's disease: disordered cellular power plant becomes a big deal in a major movement disorder.

Authors:  Yuzuru Imai; Bingwei Lu
Journal:  Curr Opin Neurobiol       Date:  2011-11-01       Impact factor: 6.627

Review 3.  Safety and Tolerability of Pharmacotherapies for Parkinson's Disease in Geriatric Patients.

Authors:  Martin Klietz; Stephan Greten; Florian Wegner; Günter U Höglinger
Journal:  Drugs Aging       Date:  2019-06       Impact factor: 3.923

4.  Mitophagy and Mitochondrial Quality Control Mechanisms in the Heart.

Authors:  Roberta A Gottlieb; Amandine Thomas
Journal:  Curr Pathobiol Rep       Date:  2017-05-02

5.  PINK1-phosphorylated mitofusin 2 is a Parkin receptor for culling damaged mitochondria.

Authors:  Yun Chen; Gerald W Dorn
Journal:  Science       Date:  2013-04-26       Impact factor: 47.728

Review 6.  Mitochondrial dynamics and cell death in heart failure.

Authors:  José Marín-García; Alexander T Akhmedov
Journal:  Heart Fail Rev       Date:  2016-03       Impact factor: 4.214

Review 7.  Targeting mitochondria for cardiovascular disorders: therapeutic potential and obstacles.

Authors:  Massimo Bonora; Mariusz R Wieckowski; David A Sinclair; Guido Kroemer; Paolo Pinton; Lorenzo Galluzzi
Journal:  Nat Rev Cardiol       Date:  2019-01       Impact factor: 32.419

Review 8.  Pathologic and therapeutic implications for the cell biology of parkin.

Authors:  Rakshita A Charan; Matthew J LaVoie
Journal:  Mol Cell Neurosci       Date:  2015-02-17       Impact factor: 4.314

Review 9.  Mitoconfusion: noncanonical functioning of dynamism factors in static mitochondria of the heart.

Authors:  Moshi Song; Gerald W Dorn
Journal:  Cell Metab       Date:  2015-02-03       Impact factor: 27.287

10.  Mitochondrial contagion induced by Parkin deficiency in Drosophila hearts and its containment by suppressing mitofusin.

Authors:  Poonam Bhandari; Moshi Song; Yun Chen; Yan Burelle; Gerald W Dorn
Journal:  Circ Res       Date:  2013-11-05       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.